Clinical Pharmacology of If Current Inhibition

Publisher： Karger

E-ISSN： 1424-0556|5|1|21-24

ISSN： 1422-9528

Source： Heart Drug, Vol.5, Iss.1, 2005-02, pp. : 21-24

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial Current Clinical Pharmacology: 2014 and Beyond

By  

Current Clinical Pharmacology, Vol. 9, Iss. 1, 2014-02 ,pp. : 1-1

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Pharmacology of Current and Future Drugs for the Acute Treatment of Migraine: A Review and An Update

By  

Current Clinical Pharmacology, Vol. 7, Iss. 1, 2012-02 ,pp. : 66-72

Bentham Science Publishers

Access to resources Recommend Favorite

Topoisomerase I inhibition with topotecan: pharmacologic and clinical issues

By Arun B.   Frenkel E.P.  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 3, 2001-03 ,pp. : 491-505

Informa Healthcare

Access to resources Recommend Favorite

Ergot Alkaloids: Current Status and Review of Clinical Pharmacology and Therapeutic Use Compared with Other Oxytocics in Obstetrics and Gynaecology

By N.J.A. de Groot A.  

Drugs, Vol. 56, Iss. 4, 1998-10 ,pp. : 523-535

Adis International

Access to resources Recommend Favorite

The Pharmacology and Clinical Outcomes of Amphetamines to Treat ADHD: Does Composition Matter?

By Hodgkins Paul  

CNS Drugs, Vol. 26, Iss. 3, 2012-03 ,pp. : 245-268

Adis International

Access to resources Recommend Favorite